Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ALT-946

Known as: N-(2-acetamidoethyl)hydrazinecarboximidamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Context: Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological… Expand
  • table 1
  • table 2
2006
2006
  • C. McEniery
  • British journal of pharmacology
  • 2006
  • Corpus ID: 24756387
British Journal of Pharmacology (2006) 148, 881–883. doi:10.1038/sj.bjp.0706805 
Review
2005
Review
2005
Prolonged hyperglycemia, dyslipidemia and oxidative stress in diabetes result in the production and accumulation of AGEs. It is… Expand
Highly Cited
2002
Highly Cited
2002
The severe diabetic nephropathy that develops in the hypertensive transgenic (mRen-2)27 rat with streptozotocin (STZ) diabetes… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2001
Highly Cited
2001
Aims/hypothesis. ALT-946, an inhibitor of advanced glycation with a minimal inhibitory effect on nitric oxide synthase, was… Expand